NYSE:GKOS

Glaukos Stock Predictions

Healthcare > Medical - Devices

Buy GKOS

*Your capital is at risk

$113.64

+2.86 (+2.58%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

GKOS Prediction Chart

GKOS Predictions History

Latest community submissions for GKOS.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
NameNotImportant Pro	May 2, 2019	$70.24 -1.24%	$71.12	X	98.76%	1
NameNotImportant Pro	Apr 29, 2019	$74.77 +4.76%	$71.37	X	95.24%	0
Vic.Bar.2856	Feb 13, 2017	$28.69 -35.77%	$44.67	X	64.20%	0
PumpTheseNumbers Pro	Apr 18, 2016	$18.00 -5.81%	$19.11	X	94.20%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for GKOS with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT GLAUKOS CORPORATION

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stent...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by